Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Akela Pharma, a drug development company, has announced that its wholly owned subsidiary, PharmaForm, has signed a development agreement with an undisclosed global pharmaceutical company, to develop specialized oral dosage forms at its facility located in Austin, Texas.
Subscribe to our email newsletter
Under the terms of the agreement, PharmaForm will develop products in one or more therapeutic areas utilizing PharmaForm’s core expertise in hot melt extrusion.
In addition to providing contract formulation services, PharmaForm will be entitled to royalty payments upon product commercialization.